LOS ANGELES--(BUSINESS WIRE)--Cougar Biotechnology, Inc. (NASDAQ:CGRB) today announced that Alan H. Auerbach, Chief Executive Officer and President of Cougar, will present at the 2008 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference on Wednesday, February 6, at 11:00 a.m. EST at the Grand Hyatt Hotel in New York City. Mr. Auerbach will provide a company overview and update on the status of Cougar’s current clinical development programs.
